Changes in Gene Expression Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer
Juliane Hannemann(Universität Hamburg), Marc J. van de Vijver(The Netherlands Cancer Institute), Lodewyk F.A. Wessels(The Netherlands Cancer Institute), Arno Velds(The Netherlands Cancer Institute), Emiel J. Rutgers(Oncode Institute), Hendrika M. Oosterkamp(The Netherlands Cancer Institute), Claudette E. Loo(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Cathy A.J. Bosch(The Netherlands Cancer Institute), Sjoerd Rodenhuis(The Netherlands Cancer Institute)
Cited by 206
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k